Viewing StudyNCT03896581



Ignite Creation Date: 2024-05-06 @ 12:57 PM
Last Modification Date: 2024-10-26 @ 1:07 PM
Study NCT ID: NCT03896581
Status: COMPLETED
Last Update Posted: 2024-04-04
First Post: 2019-03-21

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-03-28
Start Date Type: ACTUAL
Primary Completion Date: 2021-12-08
Primary Completion Date Type: ACTUAL
Completion Date: 2022-02-14
Completion Date Type: ACTUAL
First Submit Date: 2019-03-21
First Submit QC Date: March 27 2019
Study First Post Date: 2019-04-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2022-12-07
Disp First Submit QC Date: December 7 2022
Disp First Post Date: 2022-12-12
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-09-19
Last Update Post Date: 2024-04-04
Last Update Post Date Type: ACTUAL